Month: July 2024

ADA Assay Considerations: Rely on Sword Bio’s Unparalleled Expertise

ADA Assay Considerations

The Positive Control (PC) reagent is pivotal when embarking on a new anti-drug antibody (ADA) assay. Regulatory agencies typically favor polyclonal PCs because they represent the in vivo immunological response. While they have accepted monoclonal PCs, they often inquire about the rationale behind this choice. For straightforward biotherapeutics, a simple explanation suffices. However, as the complexity…

Read More...